Progress in prevention and treatment of mother-to-child transmission of hepatitis B virus

VernacularTitle:乙型肝炎病毒母婴传播的防治进展
Author: Fangfang SUN ¹ ; Cheng CHENG ; Huihui LU ; Zhan ZENG ; Minghui LI ; Yao XIE
Author Information

1. 首都医科大学附属北京地坛医院肝病二科　100015
Keywords: Hepatitis B virus; Vertical; Antiviral therapy; Vaccination
From: Chinese Journal of Experimental and Clinical Virology 2021;35(4):472-475
CountryChina
Language:Chinese
Abstract: Hepatitis B virus (HBV) is one of the infectious viruses that seriously endanger human health. There are more than 257 million people infected with chronic HBV in the world, and about and about 887 thousand people die of cirrhosis, liver failure and hepatocellular carcinoma caused by chronic HBV infection every year. It has caused serious harm to society and individuals. In China, the main route of transmission of chronic hepatitis B is mother-to-child transmission (MTCT). Therefore, blocking MTCT of HBV is an important measure to prevent the occurrence and development of hepatitis B. This article is to review the related research on blocking HBV MTCT at home and abroad, hoping to provide help for clinical practice.